The Globe and Mail offers the most authoritative news in Canada, featuring national and international news
Event summary produced by The Globe and Mail Events team. The Globe’s editorial department was not involved.
Acquiring a business can be an advantageous way to expand your market share and grow your revenue. But there is risk involved. On Tuesday, October 24, 2023, The Globe and Mail hosted a webcast featuring experts sharing their advice on the common challenges associated with buying a business, the handover process and how to mitigate risk before and after purchase.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
October jobs report: Signs of a labor market cooldown, slowing wage growth in focusInvestors are looking to the jobs report for clues on whether the economy is running too hot for inflation to come down.
Lire la suite »
Canada’s health spending growth ‘modest,’ remains below pre-pandemic levels: CIHIGrowth in Canada's health spending increased slightly but has remained below pre-pandemic levels and is expected to reach $344 billion in 2023, new data fro
Lire la suite »
Gold production growth comes from cost discipline: Barrick Gold CEOBarrick Gold exceeded analyst expectations by producing more gold at a lower cost in its latest quarter and the company’s chief executive offer says it’s because of their disciplined approach to cost management.
Lire la suite »
US Holiday Sales Growth to Moderate This Year, Retail Group SaysUS holiday sales will grow at a slower pace this year amid economic headwinds such as higher interest rates, the National Retail Federation said Thursday.
Lire la suite »
BOE’s Bleak UK Growth Forecasts Set Up Sharp Rate Cuts for 2024Bank of England Governor Andrew Bailey may insist that it is “much too early to be thinking about rate cuts,” but the financial markets have other ideas.
Lire la suite »
Diabetes, weight loss drugs drive growth for Novo and Lilly despite shortagesNovo Nordisk is aggressively pursuing large employers to ensure they continue to cover popular weight loss drugs like Ozempic and Wegovy.
Lire la suite »